FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 230 filers reported holding FIBROGEN INC in Q1 2019. The put-call ratio across all filers is 11.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $940,000 | -17.1% | 25,340 | -4.2% | 0.00% | 0.0% |
Q4 2019 | $1,134,000 | -56.1% | 26,459 | -61.8% | 0.00% | -66.7% |
Q3 2019 | $2,581,000 | -17.6% | 69,288 | -0.1% | 0.00% | 0.0% |
Q2 2019 | $3,134,000 | +17.3% | 69,359 | +41.1% | 0.00% | 0.0% |
Q1 2019 | $2,672,000 | +141.6% | 49,162 | +104.5% | 0.00% | +200.0% |
Q4 2018 | $1,106,000 | +59.8% | 24,038 | +111.1% | 0.00% | 0.0% |
Q3 2018 | $692,000 | +24.9% | 11,388 | +28.8% | 0.00% | 0.0% |
Q2 2018 | $554,000 | +4.1% | 8,843 | -23.1% | 0.00% | 0.0% |
Q1 2018 | $532,000 | +11.8% | 11,506 | +14.6% | 0.00% | – |
Q4 2017 | $476,000 | -23.3% | 10,044 | -13.0% | 0.00% | -100.0% |
Q3 2017 | $621,000 | – | 11,544 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |